Compare · BIDU vs TEM
BIDU vs TEM
Side-by-side comparison of Baidu Inc. ADS (BIDU) and Tempus AI Inc. (TEM): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BIDU and TEM operate in Computer Software: Programming Data Processing (Technology), so they compete in similar markets.
- BIDU is the larger of the two at $27.85B, about 2.2x TEM ($12.40B).
- BIDU has been more active in the news (13 items in the past 4 weeks vs 11 for TEM).
- Both have 25 recent analyst ratings on file.
- Company
- Baidu Inc. ADS
- Tempus AI Inc.
- Price
- -
- -
- Market cap
- $27.85B
- $12.40B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Computer Software: Programming Data Processing
- Computer Software: Programming Data Processing
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2005
- 2024
- News (4w)
- 13
- 11
- Recent ratings
- 25
- 25
Baidu Inc. ADS
Baidu, Inc. provides internet search services in China. Its Baidu Core segment offers Baidu App to access search, feed, and other services using mobile devices; Baidu Search to access its search and other services; Baidu Feed that provides users with personalized timeline based on their demographics and interests; Haokan short video app; and Quanmin flash video app for users to create and share short videos. It also offers Baidu Knows, an online community where users can ask questions to other users; Baidu Wiki; Baidu Healthcare Wiki; Baidu Wenku; Baidu Scholar; Baidu Experience; Baidu Post, a social media platform; Baidu Maps, a voice-enabled mobile app that provides travel-related services; Baidu Drive; Baijiahao; and DuerOS, a smart assistant platform. In addition, this segment offers online marketing services, which include pay for performance, an auction-based services that allow customers to bid for priority placement of paid sponsored links and reach users who search for information related to their products or services; other marketing services that include display-based marketing services and other online marketing services based on performance criteria other than cost per click; mobile ecosystem, a portfolio of apps, including Baidu App, Haokan, and Baidu Post; various cloud services and solutions, such as platform as a service, software as a service, and infrastructure as a service; self-driving services, including maps, automated valet parking, autonomous navigation pilot, electric vehicles, and robotaxi fleets, as well as Xiaodu smart devices. Its iQIYI segment provides online entertainment service, including original and licensed content; and other video content, membership; and online advertising services. Baidu, Inc. has strategic partnerships with Zhejiang Geely Holding Group and China Gas Holdings Ltd. The company was formerly known as Baidu.com, Inc. Baidu, Inc. was incorporated in 2000 and is headquartered in Beijing, China.
Latest BIDU
- BIDU Investor Alert: Baidu, Inc. Securities Class Action Notice - Contact Levi & Korsinsky
- SEC Form S-8 filed by Baidu Inc. ADS
- SEC Form 6-K filed by Baidu Inc. ADS
- Levi & Korsinsky Reminds Baidu, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 13, 2026 - BIDU
- SEC Form 6-K filed by Baidu Inc. ADS
- SEC Form 6-K filed by Baidu Inc. ADS
- SEC Form 6-K filed by Baidu Inc. ADS
- SEC Form 6-K filed by Baidu Inc. ADS
- SEC Form 6-K filed by Baidu Inc. ADS
- SEC Form 6-K filed by Baidu Inc. ADS
Latest TEM
- Tempus to Report Third Quarter 2026 Financial Results on November 2
- Ambry Genetics Announces GenomeNext™, a Whole Genome Sequencing Test Solution to Improve Diagnosis for Rare Diseases
- Tempus Announces Multi-Year Collaboration with Moderna and Merck
- Amendment: SEC Form S-4/A filed by Tempus AI Inc.
- Tempus Announces 13 Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2026
- CEO, Diagnostics Schoenherr Thomas Edward sold $873,885 worth of shares (10,281 units at $85.00) as part of a pre-agreed trading plan, decreasing direct ownership by 12% to 76,740 units (SEC Form 4)
- Tempus Receives FDA Clearance for its ECG-MR AI Product Designed to Identify Undiagnosed Mitral Regurgitation
- CEO and Chairman Lefkofsky Eric P sold $19,366,630 worth of shares (250,000 units at $77.47) as part of a pre-agreed trading plan (SEC Form 4)
- SEC Form 144 filed by Tempus AI Inc.
- Tempus and Recursion Extend Existing Data License Agreement and Enter New License Agreement for Recursion’s RNA Foundation Model